Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors.

PubWeight™: 5.46‹?› | Rank: Top 1%

🔗 View Article (PMID 15827312)

Published in JAMA on April 13, 2005

Authors

Michael G Shlipak1, Linda F Fried, Mary Cushman, Teri A Manolio, Do Peterson, Catherine Stehman-Breen, Anthony Bleyer, Anne Newman, David Siscovick, Bruce Psaty

Author Affiliations

1: General Internal Medicine Section, Veterans Affairs Medical Center, and Department of Medicine, University of California, San Francisco 94121, USA. shlip@itsa.ucsf.edu

Associated clinical trials:

The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients | NCT03286712

Articles citing this

(truncated to the top 100)

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA (2009) 5.52

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA (2010) 5.37

Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52

Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Association between LDL-C and risk of myocardial infarction in CKD. J Am Soc Nephrol (2013) 2.34

Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. J Am Coll Cardiol (2010) 2.32

Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10

New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors. Urology (2015) 2.03

Effect of pioglitazone on cardiovascular outcome in diabetes and chronic kidney disease. J Am Soc Nephrol (2007) 1.92

Measurement of organ structure and function enhances understanding of the physiological basis of frailty: the Cardiovascular Health Study. J Am Geriatr Soc (2011) 1.87

Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ (2009) 1.84

Cystatin C and aging success. Arch Intern Med (2008) 1.79

Barriers to exercise participation among dialysis patients. Nephrol Dial Transplant (2011) 1.69

Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int (2008) 1.64

Adherence to a healthy lifestyle and all-cause mortality in CKD. Clin J Am Soc Nephrol (2013) 1.64

Clinical and subclinical cardiovascular disease and kidney function decline in the elderly. Atherosclerosis (2008) 1.60

The relationship between serum uric acid and chronic kidney disease among Appalachian adults. Nephrol Dial Transplant (2010) 1.60

Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol (2008) 1.56

The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. Am J Kidney Dis (2008) 1.53

Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium. Am J Kidney Dis (2013) 1.52

A physiologic index of comorbidity: relationship to mortality and disability. J Gerontol A Biol Sci Med Sci (2008) 1.48

Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest (2014) 1.46

The association between glomerular filtration rate and left ventricular function in two independent community-based cohorts of elderly. Nephrol Dial Transplant (2014) 1.46

Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PLoS One (2011) 1.35

Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2008) 1.34

Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). J Am Coll Cardiol (2009) 1.30

Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29

Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: the multi-ethnic study of atherosclerosis (MESA). Am J Kidney Dis (2008) 1.22

Atherosclerosis in CKD: differences from the general population. Nat Rev Nephrol (2010) 1.16

Cystatin C and sudden cardiac death risk in the elderly. Circ Cardiovasc Qual Outcomes (2010) 1.14

Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol (1985) (2011) 1.13

Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol (2009) 1.09

Leukocyte telomere length is associated with noninvasively measured age-related disease: The Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci (2011) 1.08

Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol (2007) 1.07

Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J (2011) 1.06

Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis. J Am Soc Nephrol (2014) 1.06

Chronic kidney disease and the risk of heart failure in men. Circ Heart Fail (2011) 1.05

Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephrol (2012) 1.05

Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Nephrol (2011) 1.05

Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2014) 1.05

Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis (2008) 1.03

Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol (2012) 1.03

Subclinical atherosclerosis measures for cardiovascular prediction in CKD. J Am Soc Nephrol (2014) 1.02

Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.01

HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction. J Am Soc Nephrol (2014) 1.01

Heritability of and mortality prediction with a longevity phenotype: the healthy aging index. J Gerontol A Biol Sci Med Sci (2013) 1.00

Longitudinal association of depressive symptoms with rapid kidney function decline and adverse clinical renal disease outcomes. Clin J Am Soc Nephrol (2011) 1.00

Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging (2012) 0.98

End stage and chronic kidney disease: associations with renal cancer. Front Oncol (2012) 0.98

Cardiovascular risk and management in chronic kidney disease. Nat Rev Nephrol (2009) 0.96

Epidemiology of chronic kidney disease in heart failure. Heart Fail Clin (2008) 0.95

Kidney function and long-term medication adherence after myocardial infarction in the elderly. Clin J Am Soc Nephrol (2011) 0.95

Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int (2015) 0.95

External validity of the cardiovascular health study: a comparison with the Medicare population. Med Care (2009) 0.95

Soluble TNF receptors and kidney dysfunction in the elderly. J Am Soc Nephrol (2014) 0.93

Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study. Am J Nephrol (2013) 0.92

Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res (2010) 0.92

Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metab Cardiovasc Dis (2009) 0.92

Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail (2009) 0.92

The risk of Parkinson disease associated with urate in a community-based cohort of older adults. Neuroepidemiology (2011) 0.92

Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev (2011) 0.91

Association of renal function with cardiac calcifications in older adults: the cardiovascular health study. Nephrol Dial Transplant (2008) 0.90

Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol (2015) 0.90

Fibroblast growth factor-23: what we know, what we don't know, and what we need to know. Nephrol Dial Transplant (2013) 0.89

Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes. Diabetes Care (2009) 0.89

Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis. Perit Dial Int (2013) 0.88

Chapter 3: Management of progression and complications of CKD. Kidney Int Suppl (2011) (2013) 0.88

ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. J Am Coll Cardiol (2009) 0.88

Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial. Eur J Appl Physiol (2010) 0.88

Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol (2011) 0.88

Thrombophilia and arteriovenous fistula survival in ESRD. Clin J Am Soc Nephrol (2013) 0.87

The effects of tai chi on the renal and cardiac functions of patients with chronic kidney and cardiovascular diseases. J Phys Ther Sci (2014) 0.87

Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol (2013) 0.87

Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol (2014) 0.86

Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens (2009) 0.86

Oncological and renal medical importance of kidney-sparing surgery. Nat Rev Urol (2013) 0.86

Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women. BMC Nephrol (2012) 0.86

Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study. BMC Res Notes (2012) 0.86

Diabetes and cardiovascular disease. Diabetes Care (2011) 0.86

Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study. PLoS One (2015) 0.85

Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease. Int J Nephrol (2013) 0.85

Cholesterol Metabolism in CKD. Am J Kidney Dis (2015) 0.84

Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers? Vasc Health Risk Manag (2005) 0.84

The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract (2011) 0.84

Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension. Clin J Am Soc Nephrol (2015) 0.84

Carotid artery intima media thickness as a surrogate marker of atherosclerosis in patient with chronic renal failure on hemodialysis. N Am J Med Sci (2012) 0.84

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis (2016) 0.83

Impact of renal dysfunction on long-term outcomes of elderly patients with acute coronary syndrome: a longitudinal, prospective observational study. BMC Nephrol (2014) 0.83

Clinical utility of novel biomarkers in the prediction of coronary heart disease. Korean Circ J (2012) 0.83

Impact of hemodialysis, left ventricular mass and FGF-23 on myocardial mechanics in end-stage renal disease: a three-dimensional speckle tracking study. Int J Cardiovasc Imaging (2014) 0.82

Renal dysfunction in burns: a review. Ann Burns Fire Disasters (2013) 0.82

Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82

Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease. J Korean Med Sci (2011) 0.81

Metabolic biomarkers for predicting cardiovascular disease. Vasc Health Risk Manag (2013) 0.81

Articles by these authors

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A (2009) 54.68

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet (2007) 13.76

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06

Collaborative care for patients with depression and chronic illnesses. N Engl J Med (2010) 8.92

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65

Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet (2011) 8.57

How to interpret a genome-wide association study. JAMA (2008) 7.54

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30

Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation (2005) 6.89

The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res (2009) 6.83

Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2005) 6.80

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med (2011) 5.82

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol (2011) 5.30

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med (2002) 4.97

Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85

Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol (2010) 4.83

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A (2006) 4.56

Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46

The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 3.90

Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85

Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation (2003) 3.76

Racial and geographic differences in awareness, treatment, and control of hypertension: the REasons for Geographic And Racial Differences in Stroke study. Stroke (2006) 3.67

Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66

Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol (2012) 3.62

Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54

The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28

Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2004) 3.26

Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA (2006) 3.26

Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet (2010) 3.24

Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care (2003) 3.21

Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke (2015) 3.17

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14

A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14

Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10

The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med (2004) 3.09

Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07

A new statistic and its power to infer membership in a genome-wide association study using genotype frequencies. Nat Genet (2009) 3.06

Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2002) 3.05

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04

The Next PAGE in understanding complex traits: design for the analysis of Population Architecture Using Genetics and Epidemiology (PAGE) Study. Am J Epidemiol (2011) 2.98

Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology (2003) 2.97

Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation (2007) 2.93

Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA (2004) 2.90

Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation (2008) 2.85

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis (2004) 2.83

Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol (2004) 2.82

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82

Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78

Cohort studies and the genetics of complex disease. Nat Genet (2009) 2.77

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76

Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72

Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch Intern Med (2003) 2.69

Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study. Arch Intern Med (2006) 2.60

Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med (2013) 2.55

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55

Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation (2006) 2.50